|
|
|
Press
Reports
|
|
|
March
2010
BioSpectrum Asia Pacific Awards 2010: Emerging company of the year: Curiox biosystems, Singapore
The pharmaceutical industry has been under increasing pressure to deliver drugs to the market faster and more efficiently. In an effort to combat this, Dr Namyong Kim, who leads a team of scientists at the Institute of Bioengineering and Nanotechnology (IBN), under the Agency for Science, Technology, and Research (A*STAR) in Singapore developed the new bioassay technology called DropArray. More
»
|
|
|
May/June
2009
Novel test detects eye ailments in
minutes, needs less tear fluids
SINGAPORE
National Eye Centre (SNEC) researchers are testing a new technology,
touted for its ability to accurately detect eye ailments more quickly
than current methods. More
»
|
|
|
Dec
17, 2007
Curiox's Mini-Bioassay Tech to Aid
Cheaper Drug Development
Curiox
Biosystems has developed a miniaturisation platform that enables
cheaper and more efficient bioassays to be conducted, potentially
slashing the costs of life science and drug discovery research. More
»
|
|
|
Dec
17, 2007
Nanotechnology Firm Invests in Singapore
Biomedical Start-up
German
nanotechnology company had decided to make a 16.5 per cent investment
in a Singapore-based start up called Curiox Biosystems. Nanostart AG
is widely seen as the world's leading nanotechnology investment
company. More »
|
|
|
|
|